Alvotech (ALVO) Assets Average (2024 - 2026)
Alvotech's (ALVO) quarterly Assets Average came in at $1.5 billion in Q2 2026, up 14.04% on a YoY basis from $1.3 billion in Q2 2025, and up 3.45% quarter-over-quarter from $1.5 billion in Q1 2026.
Analysis
Alvotech (ALVO) Assets Average (2024 - 2026) Analysis & Trends
Alvotech (ALVO) has reported Assets Average for 3 consecutive years, with $1.5 billion the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Assets Average rose 14.04% year-over-year to $1.5 billion; the trailing twelve-month figure through Jun 2026 stood at $1.5 billion (up 14.04% YoY), and the FY2025 full-year result was $1.4 billion, up 24.73% from the prior year.
- Assets Average grew to $1.5 billion in Q2 2026 per ALVO's latest filing, from $1.5 billion in the prior quarter.
- Across five years, Assets Average topped out at $1.5 billion in Q2 2026 and bottomed at $1.0 billion in Q1 2024.
- Historically, Assets Average has averaged $1.3 billion across 3 years, with a median of $1.3 billion in 2025.
- The sharpest annual moves came in 2025 and 2026: Assets Average gained 23.91% in 2025, then grew 14.04% in 2026.
- Over 3 years, Assets Average stood at $1.2 billion in 2024, then rose by 18.01% to $1.4 billion in 2025, then gained by 3.88% to $1.5 billion in 2026.
- According to Business Quant data, Assets Average over the past three periods registered $1.5 billion, $1.5 billion, and $1.4 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.84 Bn | 39.19 Bn | 2.15 Bn | 39.95 Bn |
| 2 | Viatris | 19.13 Bn | 18.24 Bn | 1.46 Bn | 35.94 Bn |
| 3 | Dr Reddys Laboratories | 9.91 Bn | 9.74 Bn | 396.53 Mn | 6.21 Bn |
| 4 | Amneal Pharmaceuticals | 5.51 Bn | 5.38 Bn | 334.51 Mn | 3.66 Bn |
| 5 | Bausch Health Companies | 2.30 Bn | 464.50 Mn | 2.10 Bn | 24.65 Bn |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn | 1.50 Bn |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | 1.46 Bn |
| 8 | Amphastar Pharmaceuticals | 1.00 Bn | 714.13 Mn | 93.47 Mn | 1.70 Bn |
| 9 | Fennec Pharmaceuticals | 402.10 Mn | 360.85 Mn | 17.15 Mn | 73.15 Mn |
| 10 | RedHill Biopharma | 178.35 Mn | 178.35 Mn | - | 21.86 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.50 Bn |
| Mar 31, 2026 | 1.45 Bn |
| Dec 31, 2025 | 1.45 Bn |
| Sep 30, 2025 | 1.40 Bn |
| Jun 30, 2025 | 1.32 Bn |
| Mar 31, 2025 | 1.23 Bn |
| Dec 31, 2024 | 1.23 Bn |
| Sep 30, 2024 | 1.15 Bn |
| Jun 30, 2024 | 1.06 Bn |
| Mar 31, 2024 | 1.01 Bn |